HCV NS5B (2594-2602) HLA-A*02:01 ALYDVVTKL

HCV NS5B (2594-2602) HLA-A*02:01 ALYDVVTKL

Order number: P2279.9501

Shipping: Shipment: not cooled. Store at -20°C. For laboratory usage only!

Delivery time: 3- 8 working days
For detailed information on the delivery date, please contact Genaxxon.

Quantity Unit price
To 2 €153.83 *
From 3 €123.06 *


Please select the favoured pack size.


Please select the favoured purity.

T cell epitopes are presented on the surface of antigen-presenting cells by MHC molecules. T... more
Product information "HCV NS5B (2594-2602) HLA-A*02:01 ALYDVVTKL"

T cell epitopes are presented on the surface of antigen-presenting cells by MHC molecules. T cell epitopes presented by MHC class I molecules are typically peptides between 8 and 11 amino acids in length and exhibiting MHC-specific sequence motifs

Results of B. Vali et al. We identified a relatively high degree of amino acid sequence similarity between HLA-A2-restricted epitopes HIV (HXB2) gag: 77-85 (SLYNTVATL: SL9) and HCV (H77) NS5b:2594-2602 (ALYDVVSKL: AL9). Of the screened HIV-infected individuals, 5 subjects showed significant response to both peptides. PBMCs from these individuals were used for tetramer analysis. Among the examined responders, three individuals showed CD8+ T-cells distinctly double-stained for both tetramers. Flow cytometry was conducted for expression analysis of IFN-g and the degranulation marker CD107a on PBMCs stained with SL9 tetramer and stimulated with either SL9 or AL9 peptides ... .

Conclusions: The preliminary findings of the group indicate a potential T-cell cross-recognition between HIV derived HLA-A2 restricted SLYNTVATL and HCV derived HLA-A2 restricted ALYDVVSKL epitopes. This degeneracy of HIV-specific T-cells may play a role in the underlying immunological mechanisms related to pathological profile of HCV/HIV co-infection and variable clinical outcomes influenced by different CD8 T-cell repertoire.

More products around "HCV NS5B (2594-2602) HLA-A*02:01 ALYDVVTKL"
Specifications: Purity: >95% (HPLC) Sequence: ALYDVVTKL HLA-type: HLA-A*02:01 lyophilized... more

Technical Data:

Purity: >95% (HPLC)
HLA-type: HLA-A*02:01
lyophilized white powder



Sicherheits Hinweise / Safety

Klassifizierungen / Classification

eclass-Nr: 32-16-04-09
Dokumente - Protokolle - Downloads more

Dokumente - Protokolle - Downloads

Here you will find information and further literature on HCV NS5B (2594-2602) HLA-A*02:01 ALYDVVTKL. For further documents (certificates with additional lot numbers, safety data sheets in other languages, further product information) please contact Genaxxon biosience at: info@genaxxon.com or phone: +49 731 3608 123.